COO, CFO AND SECRETARY
Fri, Nov 15, 2024
Nov 15
exercised or converted securities in DAWN
1,375 shares @ $0.00
Decreased holdings by -20.00%
Net across this filing: +3.30% (+7,648 shares)
Option Exercise
Sale tied to a same-time option exercise
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology